Dr. Omar Shakir joins to discuss in-office vitreoretinal surgery, including a deep dive on pros/cons, effects for the healthcare system at large, and how he responds to major criticisms.
Relevant Financial Disclosures: Dr. Shakir is a shareholder in iOR Partners.
You can claim CME credits for...
Published 06/12/24